Regulatory networks defining EMT during cancer initiation and progression
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
Epithelial to mesenchymal transition (EMT) is essential for driving plasticity during development, but is an unintentional behaviour of cells during cancer progression. The EMT-associated reprogramming of cells not only suggests that fundamental changes may occur to several regulatory networks but also that an intimate interplay exists between them. Disturbance of a controlled epithelial balance is triggered by altering several layers of regulation, including the transcriptional and translational machinery, expression of non-coding RNAs, alternative splicing and protein stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In cancer, EMT plays an important role in tumor invasion, metastasis, and resistance to various therapies [75].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [75]
Citations
Cites
1 retracted
RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3
Herranz, N., Dave, N., Millanes‐Romero, A., Morey, L., Diaz, V. M., Lorenz, V., Gallego, R. G., Jerónimo, C., Croce, L. D., de Herreros, A. G., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.002 · Cited by 80
RetractedEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Cited by
Items 601–700 of 1,004
Liu, S., Lee, W., Lai, D., Wu, S., Liu, C.-Y., Tien, H., Chiu, C., Peng, Y., Jan, Y., Chao, T., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.009 · Cited by 57
Ye, Z., Yin, S., Su, Z., Bai, M., Zhang, H., Hei, Z., & Cai, S. (2016) · Oncotarget · doi:10.18632/oncotarget.6852 · Cited by 59
“EMT is closely associated with cancer progression [20], as it is involved in three major steps of malignant cancer progression: invasion, dissemination and metastasis [3].”
BackgroundDrug Development for Metastasis Prevention
Fontebasso, Y., & Dubinett, S. M. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.150 · Cited by 66
Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
Li, B., & Huang, C. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3846 · Cited by 61
“Hallmark of EMT is the loss of E-cadherin, a dominant constituent of the adhesion junctions (4-6,14).”
InfluentialNew Insights into the Role of Epithelial–Mesenchymal Transition during Aging
Santos, F. D. S., Moreira, C., Pereira, S. N., & de Jesus, B. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040891 · Cited by 61
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer
Ma, T., Liang, Y., Li, Y., Song, X., Zhang, N., Li, X., Chen, B., Zhao, W., Wang, L., & Yang, Q. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109536 · Cited by 59
CENP-A overexpression promotes distinct fates in human cells, depending on p53 status
Jeffery, D., Gatto, A., Podsypanina, K., Renaud-Pageot, C., Landete, R. P., Bonneville, L., Dumont, M., Fachinetti, D., & Almouzni, G. (2021) · Communications Biology · doi:10.1038/s42003-021-01941-5 · Cited by 64
Ru, N., Wu, J., Chen, Z., & Bian, H. (2014) · Cell Biology International · doi:10.1002/cbin.10341 · Cited by 56
Toward Decoding the Principles of Cancer Metastasis Circuits
Lu, M., Jolly, M. K., Onuchic, J. N., & Ben‐Jacob, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3367 · Cited by 63
Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)
Tang, J., Li, Y., Xia, S., Li, J., Yang, Q., Ding, K., & Zhang, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5257 · Cited by 61
“The EMT renders most cancer cells aggres‐ sive (128).”
BackgroundZheng, X., Ma, Y., Bai, Y., Huang, T., Lv, X., Deng, J., Wang, Z., Lian, W., Tong, Y., Zhang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984480 · Cited by 68
“EMT processes are a series of changes and transformations resulting from environmental stimuli, depending on the organization and signal transduction environment (60).”
BackgroundEMT and cancer stem cells: Drivers of therapy resistance and promising therapeutic targets
Jiang, M., Wang, J., Li, Y., Zhang, K., Wang, T., Bo, Z., Lu, S., Alarcón, R., Wei, R., Zhu, M., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101276 · Cited by 64
IGF-1 Regulates Cyr61 Induced Breast Cancer Cell Proliferation and Invasion
Sarkissyan, S., Sarkissyan, M., Wu, Y., Cardenas, J., Koeffler, H. P., & Vadgama, J. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103534 · Cited by 58
“E-cadherin is a wellestablished ‘‘gate-keeper’’ for cell-adhesion and loss has been associated with epithelial mesenchymal transition and increased invasiveness [30–32].”
BackgroundThe architect who never sleeps: Tumor‐induced plasticity
Varga, J., Oliveira, T. D., & Greten, F. R. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.06.019 · Cited by 61
“It is necessary to point out that induction of EMP in cancer cells is not necessarily an intrinsic phenomenon during tumor progression, yet, it has been suggested as a response to extracellular signals from the tumor microenvironment [25–32].”
BackgroundCui, X., Zhang, S.-M., Xu, Y., Dang, H., Liu, C., Wang, L., Yang, L., Hu, J., Liang, W., Jiang, J., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0884-y · Cited by 56
“Some reports showed that several EMTinducing transcription factors, such as Snail, Slug and ZEB1, could directly or indirectly repress E-cadherin to promote invasion and metastasis [52, 53].”
Ruocco, F. D., Basso, V., Rivoire, M. L., Mehlen, P., Ambati, J., Falco, S. D., & Tarallo, V. (2017) · Oncogene · doi:10.1038/onc.2017.369 · Cited by 57
PCAT-1: A Novel Oncogenic Long Non-Coding RNA in Human Cancers
Xiong, T., Li, J., Chen, F., & Zhang, F. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30970 · Cited by 59
“EMT is considered as an important mechanism of tumor metastasis, which promotes tumor migration, invasion and metastasis [74, 75].”
BackgroundMicroRNA-183 in Cancer Progression
Cao, D., Di, M., Liang, J., Shi, S., Tan, Q., & Wang, Z. (2020) · Journal of Cancer · doi:10.7150/jca.39044 · Cited by 62
“In malignant epithelial cells, ZEB1 acts as an activator of EMT, triggering the phenotype transformation of epithelial cells to mesenchymal cells [18].”
BackgroundClaudin‐2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription
Wei, M., Zhang, Y., Yang, X., Ma, P., Li, Y., Wu, Y., Chen, X., Deng, X., Yang, T., Mao, X., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.667 · Cited by 63
Zhu, X., Zhong, J., Zhao, Z., Sheng, J., Wang, J., Liu, J., Cui, K., Chang, J. C., Zhao, H., & Wong, S. T. C. (2015) · Oncotarget · doi:10.18632/oncotarget.4659 · Cited by 63
“EMT is a fundamental process in organ fibrosis and has been demonstrated to be closely related to cancer progression [23].”
Regulation of Epithelial-Mesenchymal Transition in Breast Cancer Cells by Cell Contact and Adhesion
Cichon, M. A., Nelson, C. M., & Radisky, D. C. (2015) · Cancer Informatics · doi:10.4137/cin.s18965 · Cited by 64
CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma
Teodorczyk, M., Kleber, S., Wollny, D., Sefrin, J. P., Aykut, B., Mateos, Á., Herhaus, P., Sancho-Martinez, I., Hill, O., Gieffers, C., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.217 · Cited by 65
“During this process, the tumour cells master the ability to detach from their neighbours and gain motile and invasive properties enabling them to spread via blood or lymph vessels.(5) As cells undergo EMT, they lose their epithelial features including sheet-like architecture, polarity and E-cadherin expression and gra…”
BackgroundVDR Status Arbitrates the Prometastatic Effects of Tumor-Associated Macrophages
Zhang, Y., Guo, Q., Zhang, Z., Bai, N., Liu, Z., Xiong, M., Wei, Y., Xiang, R., & Tan, X. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0036 · Cited by 59
“Previous studies have suggested that the loss of E-cadherin is the initial and essential step for EMT (20).”
BackgroundTian, H., Ge, C., Li, H., Zhao, F., Hou, H., Chen, T., Jiang, G., Xie, H., Cui, Y., Yao, M., et al. (2013) · Hepatology · doi:10.1002/hep.26929 · Cited by 58
“EMT is associated with invasion and metastasis of tumor.(5) As a feature of aggressive tumors, EMT is characterized by the down-regulation of E-cadherin expression and upregulation of N-cadherin expression.”
BackgroundZadran, S., Arumugam, R., Herschman, H., Phelps, M. E., & Levine, R. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414714111 · Cited by 58
“Here we use an alternative approach, surprisal analysis (8), to better understand, characterize, and represent gene expression differences critical to the EMT (4, 9).”
BackgroundMethodNam, E.-H., Lee, Y., Moon, B., Lee, S. E., & Kim, S. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv005 · Cited by 59
“It is expressed in breast, liver, prostate, gastric, colorectal, and other types of cancers, and its expression is usually associated with invasive and metastatic phenotypes (6,10,11).”
BackgroundTransition to resistance: An unexpected role of the EMT in cancer chemoresistance
Wang, J., Wei, Q., Wang, X., Tang, S., Liu, H., Zhang, F., Mohammed, M. K., Huang, J., Guo, D., Lu, M., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.01.002 · Cited by 68
ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression
Chen, Y., Lu, X., Montoya-Durango, D. E., Liu, Y.-H., Dean, K. C., Darling, D. S., Kaplan, H. J., Dean, D. C., Gao, L., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00079-x · Cited by 61
FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis
Xie, F., Jin, K., Shao, L., Fan, Y., Tu, Y., Li, Y., Yang, B., van Dam, H., ten Dijke, P., Weng, H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15021 · Cited by 58
Hsieh, Y., Liao, C., Chen, W., Pai, J., & Weng, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26128 · Cited by 55
“Epithelial-to-mesenchymal transition is well known in involving cancer cell malignant and metastasis [De Craene and Berx, 2013].”
BackgroundGuo, C., Ma, J., Deng, G., Qu, Y., Yin, L., Li, Y., Han, Y., Cai, C., Shen, H., & Zeng, S. (2017) · Journal of Cancer · doi:10.7150/jca.20952 · Cited by 57
“A set of transcriptional factors are reportedly involved in the occurrence of EMT [9, 13].”
BackgroundTargeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer
Hata, T., Rajabi, H. N., Yamamoto, M., Jin, C., Ahmad, R., Zhang, Y., Kui, L., Li, W., Yasumizu, Y., Hong, D., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0156 · Cited by 59
“EMT is also involved in pathologic processes, such as wound healing and cancer (2, 4).”
BackgroundCheng, H., Xu, Q., Lu, X., Yuan, H., Li, T., Zhang, Y., & Tan, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00896 · Cited by 58
“Epithelial-mesenchymal transition (EMT) is a cell-biological program that confersmesenchymal traits to both normal and neoplastic epithelial cells (7).”
BackgroundRole of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment
Oh‐Hohenhorst, S. J., & Lange, T. (2021) · Cancers · doi:10.3390/cancers13174492 · Cited by 56
“At least four fundamental regulatory networks orchestrate the EMT program: (i) transcriptional control, (ii) regulation from small non-coding RNAs, (iii) differential splicing, and (iv) translational and posttranslational control [41].”
BackgroundTangsiri, M., Hheidari, A., Liaghat, M., Razlansari, M., Ebrahimi, N., Akbari, A., Varnosfaderani, S. M. N., Maleki‐Sheikhabadi, F., Norouzi, A., Bakhtiyari, M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115973 · Cited by 53
Zhang, P., Huang, C., Fu, C., Tian, Y., Hu, Y., Wang, B., Strasner, A., Song, Y., & Song, E. (2015) · Oncotarget · doi:10.18632/oncotarget.3383 · Cited by 60
“EMT plays important roles in melanoma metastasis [37].”
Craene, B. D., Denecker, G., Vermassen, P., Taminau, J., Mauch, C., Derore, A., Jonkers, J., Fuchs, E. V., & Berx, G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.148 · Cited by 61
“Once the tumour has achieved the dedifferentiated state of single-cell dissemination, metastatic spread is increased and prognosis is exacerbated.(2) The transcription factor Snail (Snail homolog 1, Snai1) is a direct transcriptional repressor of E-cadherin(3,4) and its overexpression in vitro and subsequent microarra…”
BackgroundSelf-citationFabris, L., Brivio, S., Cadamuro, M., & Strazzabosco, M. (2016) · Stem Cells International · doi:10.1155/2016/2953727 · Cited by 59
EEF1D modulates proliferation and epithelial–mesenchymal transition in oral squamous cell carcinoma
Flores, I. L., Kawahara, R., Miguel, M. C. D. C., Granato, D. C., Domingues, R. R., Macedo, C. C. S., Carnielli, C. M., Yokoo, S., Rodrigues, P. C., Monteiro, B. V. D. B., et al. (2016) · Clinical Science · doi:10.1042/cs20150646 · Cited by 54
Platelets surrounding primary tumor cells are related to chemoresistance
Ishikawa, S., Miyashita, T., Inokuchi, M., Hayashi, H., Oyama, K., Tajima, H., Takamura, H., Ninomiya, I., Ahmed, A. K., Harman, J. W., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4898 · Cited by 58
Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells
Lee, H.-M., Patel, V., Shyur, L., & Lee, W.-L. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.09.005 · Cited by 54
Growth Hormone and the Epithelial-to-Mesenchymal Transition
Brittain, A. L., Basu, R., Qian, Y., & Kopchick, J. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01000 · Cited by 60
Zhang, H., Zhang, Y., Chen, C., Zhu, X., Zhang, C., Xia, Y., Zhao, Y., ANDRISANI, O. M., & Kong, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.021 · Cited by 56
Krogh, N., Asmar, F., Côme, C., Munch‐Petersen, H. F., Grønbæk, K., & Nielsen, H. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa035 · Cited by 69
“as observed in comparisons between developmental and pathological epithelial–mesenchymal transition (EMT) (38,39).”
BackgroundLiu, G., Li, Q., Zhang, P.-F., Shen, S., Xie, W., Чэн, Б., Wu, J. H., Hu, W., Huang, X., & Peng, B. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1165-x · Cited by 54
Fan, Y. J., Wang, Y., Su, H., Fang, N., Zou, C., Li, W., & Fei, Z. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0288-8 · Cited by 53
“The EMT plays crucial roles during cancer initiation and progression, especially in cancer metastasis [20–22].”
BackgroundRetractedMaharati, A., & Moghbeli, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04434-7 · Cited by 55
“Multiple intracellular and extracellular pathways also regulate the expression of these critical transcription factors [122].”
BackgroundHutchinson, R. A., Adams, R., McArt, D. G., Salto‐Tellez, M., Jasani, B., & Hamilton, P. W. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0531-z · Cited by 60
“Molecular interactions are both intracellular and extracellular, and so it is a reasonable assumption that the internalisation and cytoplasmic accumulation of EGFR may indeed alter tumour cell morphology, metabolism and confer an invasive cellular phenotype [88, 89].”
BackgroundDeregulation of splicing factors and breast cancer development
Silipo, M., Gautrey, H., & Tyson-Capper, A. J. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv027 · Cited by 59
“During EMT, tumour cells acquire migratory and invasive properties which lead to a metastatic phase in different tumour tissues included breast (De Craene and Berx, 2013).”
BackgroundRole of fucosyltransferase IV in epithelial–mesenchymal transition in breast cancer cells
Yang, X., Liu, S., & Yan, Q. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.241 · Cited by 57
“The strength of EMT is primarily dependent on the potency of EMT-inducing transcription factors that are capable of triggering cellular reprogramming.(49) Snail factors also directly regulate epithelial and mesenchymal markers.”
BackgroundCollagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma Cells
Clementz, A. G., Mutolo, M. J., Leir, S., Morris, K. J., Kucybala, K., Harris, H., & Harris, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072250 · Cited by 53
RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis
Huang, Y.-T., Zhao, M., Xu, H., Wang, K., Fu, Z., Jiang, Y., & Yao, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2244 · Cited by 56
“The transition includes the loss of epithelial features, such as cellular polarization, in conjunction with the acquisition of mesenchymal properties, such as invasive and migratory Oncotarget6735www.impactjournals.com/oncotarget capacity, as well as other biological abilities, such as escape from apoptosis and secret…”
BackgroundKatsura, A., Suzuki, H. I., Ueno, T., Mihira, H., Yamazaki, T., Yasuda, T., Watabe, T., Mano, H., Yamada, Y., & Miyazono, K. (2015) · Genes to Cells · doi:10.1111/gtc.12323 · Cited by 56
“During EMT, several transcriptional factors including Snail, Slug, ZEB1, ZEB2, Twist and E12/E47, which are regulated by TGF-b, mediate repression of E-cadherin, an epithelial marker (De Craene & Berx 2013).”
BackgroundZhang, G., Tian, X., Li, Y., Wang, Z., Li, X., & Zhu, C. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.163 · Cited by 57
Chen, L., Li, Y., Wu, L., Yu, G., Zhang, W., Huang, C., & Sun, Z. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13439 · Cited by 54
Li, H., Bi, Y.-R., Yang, L., Fu, R., Lv, W.-C., Jiang, N., Xu, Y., Ren, B., Chen, Y., Xie, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaw8500 · Cited by 59
Ahuja, N., Ashok, C., Natua, S., Pant, D., Cherian, A., Pandkar, M. R., Yadav, P., Vishnu Narayanan, S. S., Mishra, J., Samaiya, A., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa021 · Cited by 57
“EMT is known to be induced under hypoxia via altered expression of a plethora of transcription and splicing factors (46).”
Teng, Y., Zhao, L., Zhang, Y., Chen, W., & Li, X. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358647 · Cited by 53
SMAD7: a timer of tumor progression targeting TGF-β signaling
Luo, L., Li, N., Lv, N., & Huang, D. (2014) · Tumor Biology · doi:10.1007/s13277-014-2203-7 · Cited by 57
“[9, 10]).”
The biological role of epithelial-mesenchymal transition in lung cancer (Review)
Sung, W. J., Kim, H., & Park, K. (2016) · Oncology Reports · doi:10.3892/or.2016.4964 · Cited by 56
“The Notch signaling pathway participates in the establishment of motile and invasive mesenchymal phenotypes from polarized epithelial properties, involving downregulation of epithelial markers and upregulation of mesenchymal markers (48,49).”
BackgroundMicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer
Behbahani, G. D., Ghahhari, N. M., Javidi, M. A., Molan, A. F., Feizi, N., & Babashah, S. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0101-6 · Cited by 53
“EMT-TFs include three families: the zinc finger SNAIL (Snail1 and Snail2/ Slug), ZEB (Zeb1and Zeb2/SIP1) and basic helix-loop-helix transcription factors (Twist1, Twist2 and E12/E47) [1] [2].”
BackgroundUpregulation of MiR-205 under hypoxia promotes epithelial–mesenchymal transition by targeting ASPP2
Wang, X., Yu, M., Zhao, K., He, M., Ge, W., Sun, Y., Wang, Y., Sun, H., & Hu, Y. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.412 · Cited by 54
“Molecular and cellular biology 2004, 24(3): 1341-1350.”
InfluentialCheng, H., Lu, C., Tang, R., Pan, Y., Bao, S., Qiu, Y., & Xie, M. (2017) · Oncotarget · doi:10.18632/oncotarget.14811 · Cited by 55
“Low expression of E-cadherin is significantly related to poor tumor differentiation, invasion and metastasis [28], and this might be regulated by activating its transcription factors, such as Snail, SIP1 and Slug [29].”
BackgroundAmbrosio, S., Saccà, C. D., & Majello, B. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.07.001 · Cited by 55
Fustaino, V., Presutti, D., Colombo, T., Cardinali, B., Papoff, G., Brandi, R., Bertolazzi, P., Felici, G., & Ruberti, G. (2017) · Oncotarget · doi:10.18632/oncotarget.21132 · Cited by 62
Xu, S., Zhan, M., & Wang, J. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.69 · Cited by 56
miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma
Vosgha, H., Ariana, A., Smith, R. A., & Lam, A. K.-Y. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0497 · Cited by 56
Dai, J., Qin, L., Chen, Y., Wang, H., Lin, G., Li, X., Liao, H., & Fang, H. (2018) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2018.10.012 · Cited by 58
POFUT1 as a Promising Novel Biomarker of Colorectal Cancer
Chabanais, J., Labrousse, F., Chaunavel, A., Germot, A., & Maftah, A. A. (2018) · Cancers · doi:10.3390/cancers10110411 · Cited by 55
UPR: An Upstream Signal to EMT Induction in Cancer
Santamaría, P. G., Mazón, M. J., Eraso, P., & Portillo, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050624 · Cited by 59
“Hence, the transcription of EMT-TFs and their activity are tightly regulated by numerous layers and they act in distinct combinations to either activate or repress genes ultimately responsible for the features associated with a mesenchymal-like state during carcinoma progression [22,32].”
BackgroundKishore, C., Sundaram, S., & Karunagaran, D. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108725 · Cited by 53
Cui, J., Wang, H., Zhang, X., Sun, X., Zhang, J., & Ma, J. (2020) · Aging · doi:10.18632/aging.103036 · Cited by 57
“As a complex process, EMT is characterized by the loss of cell surface marker E-cadherin and the gain of mesenchymal markers, such as N-cadherin, vimentin, and fibronectin [42].”
BackgroundRetractedChen, X., Liu, X., Lang, H., Zhang, S., Luo, Y., & Zhang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121319 · Cited by 51
“In addition, β-catenin transportation into the nucleus can promote the expression of EMT related genes[30].”
BackgroundKucia-Tran, J., Tulkki, V., Smith, S. P., Scarpini, C. G., Hughes, K., Araujo, A. M., Yan, K. Y. M., Botthof, J. G., Pérez-Gómez, E., Quintanilla, M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.199 · Cited by 51
“A list of 16 EMT-related genes (Supplementary Table S2) was derived from published literature (Polyak and Weinberg, 2009; Nieto, 2011; Craene and Berx, 2013; Lamouille et al, 2014).”
BackgroundMethodZhang, N., Liu, Y., Wang, Y., Zhao, M., Tu, L., & Luo, F. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s129305 · Cited by 51
“thought to be responsible for gene repression.(24) Researchers have shown that TGF-β1-induced EMT in A549 cells is accompanied by histone deacetylase 6 (HDAC6)-dependent deacetylation of α-tubulin, which correlates with the expression of EMT markers.”
BackgroundKesanakurti, D., Maddirela, D. R., Banasavadi‐Siddegowda, Y., Lai, T.-H., Qamri, Z., Jacob, N. K., Sampath, D., Mohanam, S., Kaur, B., & Puduvalli, V. K. (2017) · Oncogene · doi:10.1038/onc.2016.261 · Cited by 51
Wang, X., Liang, X., Liang, H., & Wang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26342 · Cited by 56
“EMT, which is characterized as the downregulation of epithelial markers, particularly E-cadherin, and the upregulation of mesenchymal markers, particularly vimentin and N-cadherin, is a crucial step for cancer cell migration and invasion in various cancer types.(23,24) Therefore, to elucidate the underlying mechanism…”
Evanno, E., Godet, J., Piccirilli, N., Guilhot, J., Milin, S., Gombert, J. M., Fouchaq, B., & Roche, J. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0380-0 · Cited by 56
Zhou, P.-J., Xue, W., Peng, J., Wang, Y., Wei, L., Yang, Z., Zhu, H. H., Fang, Y., & Gao, W. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0609-y · Cited by 55
“More importantly, the present study showed that Par3 overexpression triggers expression of EMT-related genes such as Zeb1, Snail1, Twist1 and MMP1/9, by inactivation of metastasis-associated Hippo pathway [11].”
BackgroundInfluentialYu, S., Zhong, Q., Chen, R.-H., Han, P., Li, S.-B., Zhang, H., Li, Y., Xia, T., Zeng, M., & Huang, X.-M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0352-0 · Cited by 52
p53–Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT
Yang‐Hartwich, Y., Tedja, R., Roberts, C. M., Goodner-Bingham, J., Cardenas, C., Gurea, M., Sumi, N. J., Alvero, A. B., Glackin, C. A., & Mor, G. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0238 · Cited by 53
“org Mol Cancer Res; 17(1) January 2019 159”
BackgroundInfluentialRicca, C., Aillon, A., Viano, M., Bergandi, L., Aldieri, E., & Silvagno, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.11.006 · Cited by 52
“In epithelial tumor progression, EMT is subsequent to the localized cancer proliferation and it is considered one of the hallmarks of malignity [1,2].”
BackgroundDi, L., Liu, L., Yan, Y., Fu, R., Li, Y., Xu, Y., Cheng, Y., & Wu, Z. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1130-2 · Cited by 55
Romano, S., Tufano, M., D’Arrigo, P., Vigorito, V., Russo, S., & Romano, M. F. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.015 · Cited by 54
“transcription factors orchestrate the genetic program that leads to EMT [25,26].”
BackgroundP4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition
Cao, Y., Han, Q., Li, J., Jia, Y., Zhang, R., & Shi, H. (2020) · Journal of Cancer · doi:10.7150/jca.38401 · Cited by 53
“EMT is considered a common trait of multiple malignancies and partially responsible for the highly metastatic behaviour and aggressive nature of cancers[15, 16].”
BackgroundDMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo
Yao, S., Ye, J., Yin, M., & Yu, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.003 · Cited by 51
The tumour microenvironment of pituitary neuroendocrine tumours
Marques, P., Grossman, A. B., & Korbonits, M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100852 · Cited by 57
Angiotensin Inhibition, TGF-β and EMT in Cancer
Pallasch, F. B., & Schumacher, U. (2020) · Cancers · doi:10.3390/cancers12102785 · Cited by 60
“They can have both inductive and repressive features at the same time, depending on whether they induce an epithelial or mesenchymal phenotype [116].”
BackgroundDong, L., Ni, J., Hu, W., Chang, Y., & Li, H. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443038 · Cited by 50
Wang, Y., Yan, L., Yang, S., Xu, H., Chen, T., Dong, Z., Chen, S., Wang, W., Yang, Q., & Chen, C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28887 · Cited by 57
Wang, Y., Wang, Z., Shao, C., Lu, G., Xie, M., Wang, J., Duan, H., Li, X., Yu, W., Duan, W., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12813 · Cited by 53
“TOX3 plays a vital role in EMT procession, which may control the metastatic dissemination of cancer.(35,36) Therefore, TOX3 has a known oncogenic function in human cancers.”
BackgroundBispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Li, T., Wang, X., Niu, M., Wang, M., Zhou, J., Wu, K., & Yi, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196970 · Cited by 63
“TGF-b also induces tumor cell EMT, a critical biologic process for migration and invasion, and biological features robustly associated with metastasis (99, 100).”
BackgroundTumor Budding in Upper Gastrointestinal Carcinomas
Koelzer, V. H., Langer, R., Zlobec, I., & Lugli, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00216 · Cited by 53
“In carcinomas of the gastrointestinal tract, the visible correlate of cells undergoing EMT is thought to be the presence of single cells or small clusters of up to five cells in the tumor stroma ahead of the invasive front, termed tumor budding (TB) (6, 7, 9, 10) (Figure 1).”
BackgroundTumor Plasticity Interferes with Anti-Tumor Immunity
Chouaib, S., Janji, B., Tittarelli, A., Eggermont, A., & Thiery, J. P. (2014) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2014010183 · Cited by 50
Knockdown of FOXK1 Suppresses Proliferation, Migration, and Invasion in Prostate Cancer Cells
Chen, F., Xiong, W., Dou, K., & Ran, Q. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14871164924588 · Cited by 51
Burger, G. A., Danen, E. H. J., & Beltman, J. B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00162 · Cited by 52
“Epithelial–mesenchymal transition is regulated by a complex network of interconnected pathways such as the transforming growth factor-β (TGF β ), epidermal growth factor (EGF), insulin-like growth factor, Wnt, Hedgehog, and Notch pathway (18).”
BackgroundCancer Stem Cells and Metastasis
Nandy, S., & Lakshmanaswamy, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.007 · Cited by 52
Mao, X.-W., Xiao, J., Li, Z., Zheng, Y., & Zhang, N. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.239 · Cited by 53
Cheng, H., Ge, X., Zhuo, S., Gao, Y., Zhu, B., Zhang, J., Shang, W., Xu, D., Ge, W., & Shi, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01413 · Cited by 52
Jafari-Oliayi, A., & Asadi, M. H. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00422-6 · Cited by 50
Metadata
- Authors
- Craene, B. D., & Berx, G.
- Affiliations
- Ghent University (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Berx, Geert
- ORCID
- Berx, Geert
- Venue
- Nature Reviews Cancer
- Published
- 2013-01-24
- Volume
- 13
- Issue
- 2
- Pages
- 97-110
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2016360721
- Cited by
- 2,487
- References
- 205
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 127 · 2023: 159 · 2022: 209 · 2021: 247 · 2020: 260 · 2019: 239 · 2018: 234 · 2017: 253 · 2016: 202 · 2015: 181 · 2014: 182 · 2013: 83
- FWCI
- 22.16
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, tumor progression, tumor initiation, cellular plasticity, transcriptional regulation, translational regulation, non-coding RNA, alternative splicing, protein stability
- MeSH terms
- Animals, Epithelial Cells, Humans, Neoplasms, Disease Progression, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.